Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Bio Green Med Solution, Inc. (BGMS)

0.8708 -0.0012 (-0.14%)
As of 9:45:58 AM EST. Market Open.
Chart Range Bar
Loading chart for BGMS
  • Previous Close 0.8720
  • Open 0.8720
  • Bid 0.6091 x 200
  • Ask 1.1700 x 200
  • Day's Range 0.8708 - 0.8720
  • 52 Week Range 0.5700 - 2.8000
  • Volume 5,905
  • Avg. Volume 73,329
  • Market Cap (intraday) 5.767M
  • Beta (5Y Monthly) -0.46
  • PE Ratio (TTM) --
  • EPS (TTM) -5.0200
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

bgmsglobal.com

--

Full Time Employees

December 31

Fiscal Year Ends

Industrials

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BGMS
41.16%
S&P 500 (^GSPC)
12.58%

1-Year Return

BGMS
45.23%
S&P 500 (^GSPC)
13.81%

3-Year Return

BGMS
99.91%
S&P 500 (^GSPC)
76.82%

5-Year Return

BGMS
99.99%
S&P 500 (^GSPC)
64.67%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY24
Revenue 10k
Earnings -1.96M
Profit Margin -19,570.00%

Q4

FY23

Q1

FY24

Q2

FY24

Q3

FY24

-5M
-4M
-3M
-2M
-1M
0
-80000.0%
-60000.0%
-40000.0%
-20000.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -118.27%

  • Return on Assets (ttm)

    -37.01%

  • Return on Equity (ttm)

    34.40%

  • Revenue (ttm)

    1.86M

  • Net Income Avi to Common (ttm)

    -9.26M

  • Diluted EPS (ttm)

    -5.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.79M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3.66M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: